SBrajpal Singh Tyagi1,2* and Mamatarani Rout2
1Head of Department of ENT, Colombia Asia Hospital, Ghaziabad, India
2Head of Department of ENT, Harsh ENT Hospital, Ghaziabad, India
3Junior Consultant, Department of ENT, Harsh ENT hospital, Ghaziabad, India
*Corresponding Author: Brajpal Singh Tyagi, Head of Department of ENT, Colombia Asia Hospital and Head of Department of ENT, Harsh ENT Hospital, Ghaziabad, India.
Received: March 24, 2020; Published: April 21, 2020
Antimicrobial resistance is now a major challenge to clinicians for treating patients. Multidrug resistance (MDR) bacteria or super bugs are one of the most important current threats to public health. Typically, MDR bacteria are associated with nosocomial infections. The spread of multidrug resistance bacteria into the community is associated with increased morbidity, mortality and health care costs. Methicillin resistance Staphylococcus aureus (MRSA) is the most prevalent of MDR bacteria. Others are Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Klebsiella pneumoniae and E. coli. Antibiotic resistance accounts for about 70,000 deaths per year worldwide and is projected to be 10 million in 2050. It is estimated that nearly half of the people aged 15 to 24 years taken antibiotics which was not meant for them. Considering this, a study was conducted to know the pattern of causative superbugs and their antimicrobial sensitivity.
Keywords: Superbugs; MDR Bacteria; MRSA; Amies Transport Medium; Antibiotic Sensitivity
Citation: Brajpal Singh Tyagi and Mamatarani Rout. “An Initiative to Prevent Emergent Super Bugs in ENT Practice". Acta Scientific Otolaryngology 2.5 (2020): 09-11.
Copyright: © 2020 Brajpal Singh Tyagi and Mamatarani Rout. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.